FDA Inspection 1325074 — Heilongjiang Eppen Biotech Co., Ltd
The FDA completed an inspection of Heilongjiang Eppen Biotech Co., Ltd on June 17, 2026 in Daqing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 17, 2026
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Daqing (China)